Farther Finance Advisors’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61K Sell
17
-21
-55% -$2.1K ﹤0.01% 5232
2026
Q1
$2.55K Hold
38
﹤0.01% 4802
2025
Q4
$3K Hold
38
﹤0.01% 4534
2025
Q3
$1.28K Buy
38
+37
+3,700% +$911 ﹤0.01% 4293
2025
Q2
$14 Hold
1
﹤0.01% 4444
2025
Q1
$14 Hold
1
﹤0.01% 4209
2024
Q4
$15 Sell
1
-1
-50% -$15 ﹤0.01% 3949
2024
Q3
$31 Hold
2
﹤0.01% 3897
2024
Q2
$27 Buy
+2
New +$31 ﹤0.01% 3740

Other funds holding INBX

Farther Finance Advisors's INBX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Inhibrx (INBX) stake by 55% in Q2 2026, selling an estimated $2.1K and leaving 17 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #5232.

Farther Finance Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $3K in Q4 2025. 10 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Farther Finance Advisors held 17 shares of Inhibrx worth $1.61K as of Q2 2026.
  • Farther Finance Advisors sold 21 Inhibrx shares in Q2 2026, an estimated $2.1K.
  • Inhibrx made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5232 holding.
  • Farther Finance Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Farther Finance Advisors's Inhibrx position peaked at $3K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.